Tag: Kevin Eggan
-
Nation & World
Perspectives on gene editing
Harvard researchers, others share their views on key issues in the field
-
Nation & World
Medical hope on horizon
Stem cell science is accelerating development of therapies for diabetes, ALS, other diseases, researchers tell HUBweek sessions.
-
Nation & World
Research suggests new avenues for attacking ALS
Harvard researchers have found evidence that bone marrow transplantation may one day be beneficial to a subset of patients suffering from ALS.
-
Nation & World
Possible progress against Parkinson’s
Harvard Stem Cell Institute researchers at McLean Hospital have taken what they describe as an important step toward using the implantation of stem cell-generated neurons as a treatment for Parkinson’s disease.
-
Nation & World
A new stem cell advance
Collaborating with scientists elsewhere, Harvard Stem Cell Institute researchers have devised two methods for using stem cells to generate the type of neurons that help regulate behavioral and basic physiological functions in the human body, such as obesity and hypertension, sleep, mood, and some social disorders.
-
Nation & World
Creating pain-sensing neurons
Harvard Stem Cell Institute researchers at Boston Children’s Hospital and Harvard’s Department of Stem Cell and Regenerative Biology have successfully converted mouse and human skin cells into pain-sensing neurons that respond to a number of stimuli that cause acute and inflammatory distress.
-
Nation & World
Progress against ALS
Studies begun by Harvard Stem Cell Institute scientists eight years ago have led to a report that may be a major step in developing treatments for amyotrophic lateral sclerosis, or Lou Gehrig’s disease.
-
Nation & World
A decade of breakthroughs
The Harvard Stem Cell Institute is now 10 years old. What began as an idea embracing cross-disciplinary research quickly became a generator of scientific discoveries.
-
Nation & World
The groundwork for learning abroad
The President’s Innovation Fund for International Experiences is supporting development by faculty members of courses in Sweden, Mexico, Turkey, Shanghai, and other locations abroad to enhance the international experiences offered to Harvard students.
-
Nation & World
New hope for treating ALS
Harvard stem cell scientists have discovered that a recently approved medication for epilepsy might be a meaningful treatment for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, a uniformly fatal neurodegenerative disorder.
-
Nation & World
Big boost in drug discovery
Using a new, stem cell-based, drug-screening technology that could reinvent and greatly reduce the cost of developing pharmaceuticals, researchers at the Harvard Stem Cell Institute have found a compound that is more effective in protecting the neurons killed in amyotrophic lateral sclerosis than are two drugs that failed in human clinical trials.
-
Nation & World
Personalized medicine closer to reality
A consortium of scientists at 20 institutions, led by a principal faculty member at the Harvard Stem Cell Institute, has used stem cells to take a major step toward developing personalized medicine to treat Parkinson’s disease.
-
Nation & World
Stem cell lessons
Five years after first gaining institutional permission to attempt to produce stem cell lines via somatic cell nuclear transfer (SCNT), two Harvard researchers and a former Harvard postdoctoral fellow have closed the loop with a flurry of new studies and a commentary in several leading journals.
-
Nation & World
From skin cells to motor neurons
Harvard stem cell researchers have succeeded in reprogramming adult mouse skin cells directly into the type of motor neurons damaged in amyotrophic lateral sclerosis, best known as Lou Gehrig’s disease, and spinal muscular atrophy.
-
Nation & World
Two are Abramson winners
Kevin Eggan, associate professor of stem cell and regenerative biology, and David Elmer, assistant professor of the classics, are the winners of the 2011 Roslyn Abramson Award for excellence in undergraduate teaching.
-
Nation & World
Two studies prove value of iPS cells
A team of Harvard Stem Cell Institute (HSCI) researchers, in collaboration with scientists at Columbia University, have demonstrated that many iPS cells (stem cells created by reprogramming adult cells) are the equal of human embryonic stem cells in creating human motor neurons, the cells destroyed in a number of neurological diseases, including Parkinson’s.
-
Nation & World
Harvard Stem Cell Institute – First 5 years
What has the Harvard Stem Cell Institute accomplished in its first 5 years?
-
Nation & World
Scientists get closer to making safe patient-specific stem cells
But many scientists think the safest approach is to replace the genes altogether with so-called small molecules. In a study published online today in the journal Cell Stem Cell, researchers from the Harvard Stem Cell Institute report that a single compound they dubbed RepSox can replace two of the four key reprogramming genes.
-
Nation & World
Harvard team reports major step forward in cell reprogramming
A team of Harvard Stem Cell Institute (HSCI) researchers has made a major advance toward producing induced pluripotent stem cells, or iPS cells, that are safe enough to use in…
-
Nation & World
Concentrating on stem cells
New concentration is the latest example of the University’s commitment to and pre-eminence in the promising field of stem cell research.
-
Nation & World
Massachusetts Lt. Governor tours Harvard research facilities
Massachusetts Lt. Governor Timothy Murray on Wednesday toured Harvard labs in both Cambridge and Boston. “The Patrick Administration has been very supportive of the university research sector in Massachusetts and…
-
Nation & World
Five at Harvard named HHMI Early Career Scientists;
Five Harvard scientists are among 50 young scientists nationwide who will have their work supported for the next six years by a new initiative from the Howard Hughes Medical Institute…
-
Nation & World
Concentration in human development, regenerative biology added
Inviting a new generation of scientists into the study of human development, disease, and aging, Harvard University will offer a new undergraduate concentration in Human Developmental and Regenerative Biology (HDRB) starting this fall.
-
Nation & World
Faculty approves undergraduate concentration in human developmental, regenerative biology
Harvard’s Faculty of Arts and Sciences late today voted to approve a new undergraduate concentration, or major, in Human Development and Regenerative Biology. One of the first of its kind…
-
Nation & World
Eggan recognized by president
Harvard Stem Cell Institute (HSCI) scientist Kevin Eggan was cited by President George W. Bush for his work in advancing the field of stem cell science on both scientific and educational levels.
-
Nation & World
Stem Cell Research: The Quest Resumes
“After eight years of political ostracism, stem-cell scientists like Harvard’s Douglas Melton are coming back into the light — and making discoveries that may soon bring lifesaving breakthroughs. Scientific inspiration…
-
Nation & World
Stem cell researcher honored by President George W. Bush
Harvard Stem Cell Institute (HSCI) scientist Kevin Eggan today was cited by President George W. Bush for his work in advancing the field of stem cell science on both scientific…
-
Nation & World
Another step forward in ALS and stem cell research
A Harvard Stem Cell Institute research team has succeeded in deriving spinal motor neurons from human embryonic stem cells, and has then used them to replicate the Amyotrophic Lateral Sclerosis (ALS) disease process in a laboratory dish.
-
Nation & World
Neurons created from skin cells of elderly patients with ALS
Less than 27 months after announcing that he had institutional permission to attempt the creation of patient- and disease-specific stem cell lines, Harvard Stem Cell Institute (HSCI) principal faculty member Kevin Eggan proclaimed the effort a success — though politically imposed restrictions and scientific advances prompted him to use a different technique than originally planned.
-
Nation & World
Reprogrammed adult skin cells treat Parkinson’s disease in animal model
Researchers at the Whitehead Institute and Harvard Stem Cell Institute(HSCI) have reported successfully reducing symptoms in a Parkinson’s disease rat model by using dopamine producing neurons derived from reprogrammed adult…